Whole abdominal and pelvic irradiation in patients with minimal disease at second-look surgical reassessment for ovarian carcinoma
Journal Article
·
· Gynecol. Oncol.; (United States)
Aggressive cytoreductive surgery followed by combination chemotherapy for stage III ovarian carcinoma has resulted in a significant percentage of complete clinical responses. However, 30-50% of patients with no clinical evidence of disease are found to have residual carcinoma at second-look surgical reassessment. Because recent reports have indicated a high degree of effectiveness utilizing abdominal and pelvic irradiation as primary therapy for ovarian carcinoma with small residual disease, the authors treated eight patients found to have residual disease of less than 1 cm at second-look reassessment with either open field or split field abdominal and pelvic irradiation. All eight patients had initially undergone aggressive cytoreductive surgery and seven of the eight patients had received multidrug chemotherapy. Patients were treated either at the National Cancer Institute or the Naval Hospital Bethesda both with and without intraperitoneal radiation sensitizers. Fifty percent of the patients required early termination of therapy due to myelosuppression. All eight patients have recurred and three have died. Six of the eight patients have required major surgical procedures for gastrointestinal complications. Based on this experience, we cannot advocate this form of therapy in patients with minimal residual ovarian carcinoma following second-look surgical reassessment.
- Research Organization:
- Univ. of the Health Sciences, Bethesda, MD
- OSTI ID:
- 5610032
- Journal Information:
- Gynecol. Oncol.; (United States), Journal Name: Gynecol. Oncol.; (United States) Vol. 20:3; ISSN GYNOA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Whole abdominal irradiation following chemotherapy in advanced ovarian carcinoma
Whole abdomen radiation therapy after a short chemotherapy course and second-look laparotomy in advanced ovarian cancer
Stage II invasive adenocarcinoma of the ovary: results of treatment by whole abdominal radiation plus pelvic boost versus pelvic radiation plus oral melphalan chemotherapy
Journal Article
·
Sun Jan 31 23:00:00 EST 1988
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:5299656
Whole abdomen radiation therapy after a short chemotherapy course and second-look laparotomy in advanced ovarian cancer
Journal Article
·
Sat Jun 01 00:00:00 EDT 1991
· Gynecologic Oncology; (United States)
·
OSTI ID:6394216
Stage II invasive adenocarcinoma of the ovary: results of treatment by whole abdominal radiation plus pelvic boost versus pelvic radiation plus oral melphalan chemotherapy
Journal Article
·
Fri Jan 31 23:00:00 EST 1986
· Gynecol. Oncol.; (United States)
·
OSTI ID:5730898